安達人壽:對下半年持積極看法 料今年本港代理增至2,000人
安達人壽香港總裁暨北亞區主管張明儀表示,整體香港市場代理連續兩季沒有增長,次季市場受經濟環境影響相對較靜,但她對下半年持積極樂觀看法,相信市場會重拾增長。她指,公司目前在香港有約1,200名保險代理,目標今年可增至2,000人。
張明儀指,近年公司業務增長快,因而針對高端客戶設立財富管理中心。她表示所有保險及銀行都瞄準高端客群,整體市場持續增長,去年香港在亞洲區增長最快。但她強調香港業務不會只做高端客,否則難以快速增長。
另外,集團與內地一些醫療中心有合作,發展不限於大灣區城市。至於亞洲市場方面,除了香港,在台灣、南韓、越南等地亦有業務,亦會考慮其他地方。集團於新加坡有產險業務,暫未有打算於當地拓展人壽業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.